Biostatistics is the application of statistical methods to the design, analysis, interpretation, and reporting of clinical research data. It helps researchers determine whether observed results are meaningful, quantify uncertainty, and draw scientifically valid conclusions.
Biostatistics runs through the whole life of a clinical trial — from selecting the study design and calculating the sample size, to planning and running the analysis, and finally interpreting the findings for the Clinical Study Report.
Our approach to biostatistics emphasizes scientific rigor, pre-specified analysis methods, and results that can be translated into clinically meaningful conclusions.
We work closely with sponsors, investigators, and research teams across the major areas of biostatistics — helping ensure that every study is designed to answer its research question and that its data is analyzed and reported with care.
Selecting appropriate designs such as randomized controlled trials, cohort studies, case-control studies, and cross-sectional studies.
Determining how many participants are needed to detect a clinically meaningful treatment effect.
Developing appropriate methods for allocating participants to treatment groups.
Defining statistical methods and analyses before examining the study results.
Summarizing data using means, medians, standard deviations, proportions, and other measures.
Using statistical tests and confidence intervals to make conclusions about a population from study data.
Assessing whether observed differences or associations are likely to have occurred by chance.
Evaluating whether an investigational treatment achieves its intended clinical outcomes.
Assessing adverse events, laboratory abnormalities, vital signs, and other safety outcomes.
Analyzing time-to-event outcomes such as overall survival or progression-free survival.
Assessing and appropriately handling missing observations.
Evaluating accumulating trial data before the planned end of a study, when appropriate.
Creating analysis datasets, tables, listings, and figures using tools such as SAS, R, or Python.
Translating statistical findings into clinically meaningful conclusions.
Every trial follows the same path, with each step building on the one before it.
The protocol sets the objectives, endpoints, and population that shape every statistical decision.
Choosing the design that answers the research question with scientific validity.
Calculating how many participants are needed to detect a clinically meaningful effect.
Defining how participants are allocated to treatment groups.
Trial data is gathered in line with the protocol.
Data is reviewed and discrepancies resolved so the dataset is reliable for analysis.
Statistical methods and analyses are defined before the study results are examined.
Efficacy, safety, and other planned analyses are run as specified in the SAP.
Analysis datasets are turned into the outputs used for reporting.
Statistical findings are translated into clinically meaningful conclusions.
Results and conclusions are documented in the final report of the study.
Statistical programming creates the analysis datasets, tables, listings, and figures that turn collected trial data into reportable results, using tools such as SAS, R, or Python.
Results interpretation translates statistical findings into clinically meaningful conclusions, so that trial outcomes can support informed decisions in drug development.
Biostatistics is the application of statistical methods to the design, analysis, interpretation, and reporting of clinical research data, helping researchers quantify uncertainty and draw scientifically valid conclusions.
The SAP defines the statistical methods and analyses before the study results are examined, so the analysis is planned in advance rather than shaped by the results.
It determines how many participants are needed to detect a clinically meaningful treatment effect.
Survival analysis examines time-to-event outcomes, such as overall survival or progression-free survival.
An interim analysis evaluates accumulating trial data before the planned end of a study, when appropriate.
Analysis datasets, tables, listings, and figures are created using tools such as SAS, R, or Python.